Brief: Pharmena Eyes 1.5 Mln Zlotys In Share Issue To Test 1-MNA In COVID-19 Treatment

Pharmena SA

09/10/2020 08:56

Oct 9 (Reuters) - Pharmena SA  PHR.WA :
    * SAYS INTENDS TO ISSUE SHARES WORTH 1.5 MILLION ZLOTYS
    * MANAGEMENT WILL RECOMMEND ISSUE PRICE OF F SERIES SHARES
AT NO
MORE THAN 13.10 ZLOTYS
    * INTENDS TO ISSUE F SERIES SHARES IN PRIVATE SUBSCRIPTION
ADDRESSED TO PELION
    * SAYS PROCEEDS TO BE USED FOR DEVELOPMENT PROJECTS ON USE
OF
1-MNA IN SARS-COV-2 AND OTHER VIRAL INFECTIONS
    * SAYS 1-MNA LOWERS LEVELS OF TNF-ALPHA, MAY BE USED IN
COVID-19
TREATMENT
    * SAYS ISSUE AIMED AT FINANCING PROOF OF CONCEPT TESTS TO
DETERMINE EFFECTIVE DOSE OF 1-MNA

Source text for Eikon:  ID:nEM51WZvxa 
Further company coverage:  PHR.WA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))